share_log

OptimizeRx | 8-K: OptimizeRx Reports Strong Fourth Quarter a nd Full Year 2023 Financial Results

SEC ·  Apr 19 04:32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.